Frélii, Inc. Stock

FRLI

US3570511010

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 11:31:24 2023-09-15 EDT			5-day change	1st Jan Change
0.000100 ^USD	-.--%		-.--%	-

20-12-16	Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.	CI
20-01-08	Frélii, Inc. announced that it has received $0.203 million in funding	CI

Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ€™ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ€™ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâ€™s site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Stock Market
Stocks
FRLI Stock

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!

Market Cap	11.76M 10.12M 9.54M 8.7M 16.25M 1.12B 16.4M 114M 43.75M 570M 44.17M 43.21M 1.81B	P/E 2017	21.4x	P/E 2018	-12.5x
Enterprise Value	11.7M 10.07M 9.5M 8.65M 16.17M 1.12B 16.32M 113M 43.53M 568M 43.95M 42.99M 1.8B	EV / Sales 2017	-	EV / Sales 2018	2,167,635,443x
Free-Float	100%	Yield 2017 *	-	Yield 2018	-

20-12-16	Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.	CI
20-01-08	Frélii, Inc. announced that it has received $0.203 million in funding	CI
19-12-22	Frélii, Inc. entered into share purchase agreement to acquire 25% shares of Genecor AI Inc. for $0.94 million from Helix Investment Partners LLC.	CI
19-11-14	Frélii, Inc. announced that it has received $0.154 million in funding	CI
19-11-14	Frélii, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	CI
19-08-14	Frélii, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	CI
19-07-16	Frelii, Inc. Announces Resignation of Leslie Norris as Chief Operating Officer; Opens Its First Wholly Owned Subsidiary, Frelii Canada Inc. in Mississauga, Ontario, Canada	CI
19-06-10	Frélii, Inc. Inks Agreement with Orn Health Inc. to Support Healthcare Franchisee Partners Incorporating Pharmacogentics Into Patient Treatment	CI
19-05-22	Frelii Inc. Announces Executive Changes	CI
19-05-20	Frélii, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	CI
19-05-01	Frélii, Inc. Signs Contract and Licensing Agreement with Optivida Health	CI
19-04-16	Frélii, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	CI
19-04-12	Frélii, Inc. Announces Address Change	CI

1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0.04
10 years	0		10

Manager	Title	Age	Since
Ian Jenkins CEO	Chief Executive Officer	42	2017-04-04
Sandeep Uppal ADM	Chief Administrative Officer	-	2019-05-21
Jayson Uffens CTO	Chief Tech/Sci/R&D Officer	51	2018-05-14

Director	Title	Age	Since
Ian Jenkins BRD	Director/Board Member	42	2017-04-04
Tarek Mango BRD	Director/Board Member	55	2017-12-31
Hans Jenkins BRD	Director/Board Member	49	2018-03-26

Frélii, Inc. Stock

Stocks

FRLI

US3570511010

Advanced Medical Equipment & Technology

Valuation : Frélii, Inc.

Latest news : Frélii, Inc.

Quotes and Performance

Price Extremes

Managers and Directors : Frélii, Inc.

Medical Software & Technology Services

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FRÉLII, INC.	-.--%	-.--%	+9,900.00%	-.--%	5.9K
VEEVA SYSTEMS INC.	+0.07%	-8.23%	-4.96%	+18.46%	42.25B
PRO MEDICUS LIMITED	-1.51%	-5.52%	-44.98%	+125.57%	12.5B
SECTRA AB	-1.50%	-3.03%	-13.14%	+71.29%	5.72B
HEARTFLOW, INC.	-2.53%	-8.49%	+35.87%	-	3.96B
GENERATE BIOMEDICINES, INC.	-0.84%	-5.81%	-	-	1.98B
OMNICELL, INC.	-4.13%	-7.38%	+1.22%	-39.91%	1.47B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	+0.89%	-4.85%	-34.57%	-	1.03B
ARBUTUS BIOPHARMA CORPORATION	-0.97%	0.00%	+10.82%	+143.81%	1.01B
SUZHOU MEDICALSYSTEM TECHNOLOGY CO., LTD.	-2.29%	-8.69%	+36.90%	+43.46%	902M
Average	-1.28%	-4.22%	+1,098.57%	+51.81%	7.08B
Weighted average by Cap.	-0.63%	-6.51%	-10.09%	+45.16%

	2017	2018
Net sales	-	0.04 0.03 0.03 0.03 0.05 3.44 0.05 0.35 0.13 1.74 0.13 0.13 5.54
Net income	595K 512K 483K 440K 823K 56.93M 830K 5.75M 2.21M 28.88M 2.24M 2.19M 91.72M	-5.55M -4.77M -4.5M -4.1M -7.67M -531M -7.74M -53.63M -20.64M -269M -20.84M -20.38M -855M
Net Debt	37.06K 31.88K 30.07K 27.4K 51.22K 3.54M 51.68K 358K 138K 1.8M 139K 136K 5.71M	-58.56K -50.36K -47.52K -43.29K -80.92K -5.6M -81.65K -566K -218K -2.84M -220K -215K -9.02M